Evidence map›Paper›PMID 40247854›Full record

ReviewThe Lancet regional health. Europe2025

Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmission.

Gina E C Charnley, Tilly Alcayna, Alex Almuedo-Riera, Christiana Antoniou, Athanase Badolo, Frederic Bartumeus, Laura-Lee Boodram, Rubén Bueno-Marí, Claudia Codeço, Flavio Codeço Coelho and 15 more

Abstract readReview
In one paragraph

Review in The Lancet regional health. Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. High-resolution characterisation of diel activity rhythms inCurrent research in parasitology & vector-borne diseases · 2026
    Article
  14. Review
  15. Zika Virus: A Tale of Two Lineages.Pathogens (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Gina E C CharnleyBarcelona Supercomputing Center (BSC), Barcelona, Spain.
Tilly AlcaynaBarcelona Supercomputing Center (BSC), Barcelona, Spain.
Alex Almuedo-RieraBarcelona Institute for Global Health (ISGlobal), Universitat de Barcelona, Barcelona, Spain.
Christiana AntoniouMinistry of Health, Nicosia, Cyprus.
Athanase BadoloLaboratoire d'Entomologie Fondamentale et Appliquée, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Frederic BartumeusCentre for Advanced Studies of Blanes (CEAB-CSIC), Girona, Spain.
Laura-Lee BoodramThe Caribbean Public Health Agency, Port of Spain, Trinidad & Tobago.
Rubén Bueno-MaríEuropean Vector Control Center of Excellence, Rentokil Initial, Madrid, Spain.
Claudia CodeçoPrograma de Computação Cientifica, Fiocruz, Rio de Janeiro, Brazil.
Flavio Codeço CoelhoFundação Getulio Vargas, Rio de Janeiro, Brazil.
Federico CostaInstituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil.
Horace CoxThe Caribbean Public Health Agency, Port of Spain, Trinidad & Tobago.
Nabil HaddadMedical Laboratory Sciences Program, Division of Health Professions, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
Nurulhusna Ab HamidInstitute for Medical Research, National Institutes of Health, Ministry of Health, Malaysia.
Pattamaporn KittayapongCenter of Excellence for Vectors and Vector-Borne Diseases, Faculty of Science, Mahidol University, Nakhon Pathom, Thailand.
Gülay KorukluoğluUniversity of Health Sciences, Ankara Bilkent City Hospital, Türkiye.
Antonios MichaelakisBenaki Phytopathological Institute, Kifissia, Athens, Greece.
Rafael Maciel-de-FreitasBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Tomas MontalvoAgència de Salut Pública de Barcelona, Barcelona, Spain.
Jose MuñozBarcelona Institute for Global Health (ISGlobal), Universitat de Barcelona, Barcelona, Spain.
Silvia Sauleda OliverasBanc de Sang i Teixits, Barcelona, Spain.
John R B PalmerUniversitat Pompeu Fabra, Barcelona, Spain.
Carlos Jesús Barboza PizardMinisterio de Salud Pública de Uruguay, Montevideo, Uruguay.
Guilherme S RibeiroInstituto Gonçalo Moniz, Fiocruz, Salvador, Brazil.
Rachel LoweBarcelona Supercomputing Center (BSC), Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging vector-borne diseases (VBDs) are a major public health concern worldwide. Climate change, environmental degradation and globalisation have led to an expansion in the range of many vectors and an erosion of transmission barriers, increasing human exposure to new pathogens and the risk for emerging VBD outbreaks. Europe is potentially underprepared for the increasing threat of VBDs, due to attention and funding being diverted to other public health priorities. Proactive, rather than reactive, prevention and control approaches can greatly reduce the socio-economic toll of VBDs. Endemic countries globally have decades of experience in controlling VBDs, and Europe has much to learn from this knowledge. Here, we advocate for the expansion of transdisciplinary knowledge-sharing partnerships, to co-create proactive measures against VBDs. We present the experiences and expertise of our diverse international team and explore how an array of interventions can be applied and adapted to the European context.

Indexed as

Climate changeEmerging infectious diseasesEuropeInterventionsOne HealthVector-borne diseasesVector control

Identifiers

PMID40247854
PMCPMC12002787

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.